GIUSEPPE MINNITI

Professore di Seconda Fascia presso Università di Roma Sapienza, Dipartimento di Scienze Radiologiche, Oncologiche ed Anatomo Patologiche dal Novembre 2022;
Professore Associato (Clinical Associate Professor) di Radioterapia Oncologica presso la Facoltà di Medicina di Pittsburgh, PA, USA, Dipartimento di Radioterapia Oncologica dal 2018;
Articoli degli ultimi 5 anni:
1: Goldbrunner R, Foroglou N, Signorelli F, Schucht P, Jakola AS, Minniti G,
Rola R, Renovanz M, Preusser M, Furtner J, Grossman R, Mawrin C, Demetriades A,
Weller M, Simon M. EANS-EANO Guidelines on the extent of resection in gliomas.
Neuro Oncol. 2025 Sep 17:noaf217. doi: 10.1093/neuonc/noaf217. Epub ahead of
print. PMID: 40973061.

2: Wen PY, Weller M, Lee EQ, Touat M, Khasraw M, Rahman R, Platten M, Lim M,
Winkler F, Horbinski C, Verhaak RGW, Huang RY, Ahluwalia MS, Albert NL, Tonn JC,
Schiff D, Barnholtz-Sloan JS, Ostrom Q, Aldape KD, Batchelor TT, Bindra RS,
Chiocca EA, Cloughesy TF, DeGroot JF, French P, Galanis E, Galldiks N, Gilbert
MR, Hegi ME, Lassman AB, Le Rhun E, Mehta MP, Mellinghoff IK, Minniti G, Roth P,
Sanson M, Taphoorn MJB, von Deimling A, Weiss T, Wick W, Zadeh G, Reardon DA,
Chang SM, Short SC, van den Bent MJ, Preusser M. Glioblastoma in Adults: A
Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO)
Consensus Review on Current Management and Future Directions. Neuro Oncol. 2025
Aug 13:noaf177. doi: 10.1093/neuonc/noaf177. Epub ahead of print. PMID:
40827022.

3: Albert NL, Tabouret E, Le Rhun E, Sahm F, Furtner J, Tonn JC, Alfano C, Silva
JP, Govaerts AS, Gorlia T, Mirante O, Minniti G, Weller M, Preusser M; European
Organisation for Research and Treatment of Cancer Brain Tumor Group.
[¹⁷⁷Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1,
EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial. J Nucl Med.
2025 Aug 7:jnumed.125.269633. doi: 10.2967/jnumed.125.269633. Epub ahead of
print. PMID: 40774695.

4: Galldiks N, Lohmann P, Aboian M, Barajas RF Jr, Breen WG, Ivanidze J, Johnson
DR, Kaufmann TJ, Kim MM, Mair MJ, Minniti G, Müther M, Nabavizadeh A, Palmer JD,
Rudà R, Smits M, Tolboom N, Veldhuijzen van Zanten SEM, Veronesi MC, Werner JM,
van den Bent M, Chang SM, Langen KJ, Law I, McConathy J, Mehta M, Preusser M,
Short SC, Soffietti R, Vogelbaum M, Weller M, Wen PY, Tonn JC, Albert NL. Update
to the RANO working group and EANO recommendations for the clinical use of PET
imaging in gliomas. Lancet Oncol. 2025 Aug;26(8):e436-e447. doi:
10.1016/S1470-2045(25)00193-7. PMID: 40744043.

5: Furtner J, Berchtold L, Le Rhun E, Silvani A, Rudà R, Lombardi G, Sepúlveda-
Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Sahm F, Wick W,
Minniti G, Weller M, König F, Preusser M. Prognostic value of 1D, 2D, and
volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas:
Radiological post-hoc analysis of the EORTC-BTG-1320 trial. Neurooncol Adv. 2025
Jul 11;7(1):vdaf152. doi: 10.1093/noajnl/vdaf152. PMID: 40735273; PMCID:
PMC12305537.

6: Tini P, Donnini F, Marampon F, Vannini M, Carfagno T, Pastina P, Rubino G,
Chibbaro S, Cerase A, Bagnacci G, Perrella A, Mazzei MA, Pascucci A, D'Alonzo V,
Giacomo AMD, Minniti G. Biomolecular Predictors of Recurrence Patterns and
Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients
Treated with Radiotherapy and Temozolomide. Brain Sci. 2025 Jul 2;15(7):713.
doi: 10.3390/brainsci15070713. PMID: 40722305; PMCID: PMC12293595.

7: Michelucci R, Pauletto G, Silvani A, Pasini E, Ius T, Martinoni M, Castioni
CA, Salmaggi A, Asioli S, Maschio M, Minniti G, Franceschi E, Villani F, Rudà R,
Aronica E; Italian Multidisciplinary Group for Tumor Epilepsy. Tumor-related
epilepsy in glioma: A multidisciplinary overview. Epilepsia. 2025 Jul 5. doi:
10.1111/epi.18523. Epub ahead of print. PMID: 40616791.

8: De Felice F, Minniti G. Strategic radiotherapy: a new proof of concept.
Cancer Lett. 2025 Oct 10;630:217897. doi: 10.1016/j.canlet.2025.217897. Epub
2025 Jun 30. PMID: 40602746.

9: Gleim N, Turcas A, Minniti G, Grosu AL, Kazda T, Harat M, Fernandez S, Niyazi
M, Nicolay NH, Seidel C. Neuroprotection in radiotherapy of brain metastases - a
European pattern-of-care analysis by the ESTRO CNS Focus group. Radiother Oncol.
2025 Aug;209:111000. doi: 10.1016/j.radonc.2025.111000. Epub 2025 Jun 21. PMID:
40550425.

10: Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, Lin AL, Marcus H,
McCormack A, Minniti G, Petersenn S, Popovic V, Theodoropoulou M, Trouillas J,
Dekkers OM. Revised European Society of Endocrinology Clinical Practice
Guideline for the management of aggressive pituitary tumours and pituitary
carcinomas. Eur J Endocrinol. 2025 May 30;192(6):R45-R78. doi:
10.1093/ejendo/lvaf100. PMID: 40506054.

11: Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, Cicone F,
Daisne JF, Ducray F, Ehret F, Furtner J, Jakola AS, Niyazi M, Pellerino A,
Rasschaert M, Razis E, Sahm F, Smits M, Tolboom N, Verger A, Le Rhun E, Minniti
G, Weller M, Preusser M, Albert NL. Availability and use of PET in patients with
brain tumours - a European Organisation for Research and Treatment of Cancer -
Brain Tumour Group (EORTC-BTG) survey. Eur J Nucl Med Mol Imaging. 2025 Jun 4.
doi: 10.1007/s00259-025-07366-0. Epub ahead of print. PMID: 40464806.

12: Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F,
Koh ES, Law I, Le Rhun E, Mair MJ, Werner JM, Berghoff AS, Furtner J, Minniti G,
Scott AM, Short SC, Ivanidze J, Johnson DR, Suchorska B, Tolboom N, Tonn JC,
Verger A, Galanis E, Brastianos PK, Wen PY, Weller M, Lin NU, Preusser M. RANO
criteria for response assessment of brain metastases based on amino acid PET
imaging. Nat Med. 2025 May;31(5):1424-1430. doi: 10.1038/s41591-025-03633-7.
Epub 2025 May 8. Erratum in: Nat Med. 2025 Aug;31(8):2816. doi:
10.1038/s41591-025-03819-z. PMID: 40341837.

13: Ressa G, Levi R, Savini G, Raspagliesi L, Clerici E, Bellu L, Cappellini LA,
Grimaldi M, Pancetti S, Bono B, Franzini A, Riva M, Fernandez B, Niyazi M,
Pessina F, Minniti G, Navarria P, Scorsetti M, Politi LS. AI differentiates
radionecrosis from true progression in brain metastasis upon stereotactic
radiosurgery: analysis of 124 histologically assessed lesions. Neuro Oncol. 2025
Apr 2:noaf090. doi: 10.1093/neuonc/noaf090. Epub ahead of print. PMID: 40172476.

14: Nicosia L, Bonù ML, Angelicone I, Lunardi G, Niespolo RM, Zannetti M, Agolli
L, Chiloiro G, Romano A, Jafari F, Aghili M, Ghalehtaki R, Montesi G, De Felice
F, De Renzi F, Magli A, Le Guevelou J, Lupattelli M, Minniti G, Gambacorta MA,
Habermehl D, Franco P, Arcangeli S, Buglione M, Alongi F, Osti MF. Analysis of
patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy
with or without RT dose intensification: A multicenter retrospective study -
ATLANTIS part I. Radiother Oncol. 2025 Mar;204:110701. doi:
10.1016/j.radonc.2024.110701. Epub 2024 Dec 25. PMID: 40130646.

15: Mansouri A, Ozair A, Bhanja D, Wilding H, Mashiach E, Haque W, Mikolajewicz
N, de Macedo Filho L, Mahase SS, Machtay M, Metellus P, Dhermain F, Sheehan J,
Kondziolka D, Lunsford LD, Niranjan A, Minniti G, Li J, Kalkanis SN, Wen PY,
Kotecha R, McDermott MW, Bettegowda C, Woodworth GF, Brown PD, Sahgal A,
Ahluwalia MS. Stereotactic radiosurgery for patients with brain metastases:
current principles, expanding indications and opportunities for
multidisciplinary care. Nat Rev Clin Oncol. 2025 May;22(5):327-347. doi:
10.1038/s41571-025-01013-1. Epub 2025 Mar 19. PMID: 40108412.

16: Tomaciello M, Sciurti A, Caprara L, Conte M, Frantellizzi V, De Vincentis G,
Zaccaro L, Cunicella G, Fallico A, Cattaneo CG, Lisi R, Arcieri S, Albanese CV,
Tini P, Detti B, Di Cataldo V, Mangoni M, Francolini G, Migliara G, Livi L, De
Felice F, Minniti G, Gravina GL, Baccolini V, Marampon F. Significant
interruptions in radiotherapy during curative treatment for prostate cancer are
correlated with poorer oncological outcomes. Int J Radiat Biol.
2025;101(5):467-474. doi: 10.1080/09553002.2025.2470202. Epub 2025 Mar 4. PMID:
40036266.

17: Marampon F, Gravina GL, Cinelli E, Zaccaro L, Tomaciello M, Meglio ND,
Gentili F, Cerase A, Perrella A, Yavorska M, Aburas S, Mutti L, Mazzei MA,
Minniti G, Tini P. Reducing clinical target volume margins for multifocal
glioblastoma: a multi-institutional analysis of patterns of recurrence and
treatment response. Radiat Oncol J. 2025 Mar;43(1):13-21. doi:
10.3857/roj.2024.00059. Epub 2024 Dec 19. PMID: 39928965; PMCID: PMC12010890.

18: Nicosia L, Bonù ML, Angelicone I, Lunardi G, Niespolo RM, Zannetti M, Agolli
L, Chiloiro G, Romano A, Jafari F, Aghili M, Ghalehtaki R, Montesi G, De Felice
F, De Renzi F, Magli A, Le Guevelou J, Lupattelli M, Minniti G, Gambacorta MA,
Habermehl D, Franco P, Arcangeli S, Buglione di Monale E Bastia M, Alongi F,
Osti MF. RT for the management of locally advanced rectal cancer: Don't throw
the baby with the bath water! Radiother Oncol. 2025 Apr;205:110772. doi:
10.1016/j.radonc.2025.110772. Epub 2025 Feb 2. PMID: 39904412.

19: Morelli I, Greto D, Visani L, Lombardi G, Scorsetti M, Clerici E, Navarria
P, Minniti G, Livi L, Desideri I. Integrating nutritional status and
hematological biomarkers for enhanced prognosis prediction in glioma patients: A
systematic review. Clin Nutr ESPEN. 2025 Apr;66:269-280. doi:
10.1016/j.clnesp.2025.01.043. Epub 2025 Jan 24. PMID: 39864522.

20: Tini P, Donnini F, Minniti G. Refining target delineation strategies for
multifocal glioblastoma: a step towards personalized radiotherapy. J Neurooncol.
2025 Apr;172(2):491-492. doi: 10.1007/s11060-024-04926-6. Epub 2025 Jan 7. PMID:
39776080.

21: Weller M, Le Rhun E, Tsamtsouri L, Dummer R, Guckenberger M, Ribi K, di
Giacomo AM, Minuti G, Collazo-Lorduy A, Brandsma D, O'Brien M, Ermis E, Fischer
N, Ascierto P, Mandala M, Minniti G, Iranzo P, Roschitzki-Voser H, Ruepp B,
Grolimund E, Dafni U, Peters S, Stahel R; ETOP 19-21 USZ-STRIKE collaborators.
Immunotherapy or targeted therapy with or without stereotactic radiosurgery for
patients with brain metastases from melanoma or non-small cell lung cancer - The
ETOP 19-21 USZ-STRIKE study. Lung Cancer. 2025 Jan;199:108069. doi:
10.1016/j.lungcan.2024.108069. Epub 2024 Dec 22. PMID: 39731865.

22: Duerinck J, Karschnia P, Broekman M, Gempt J, Petrescu GED, Jakola AS,
Grossman R, Goldbrunner R, Jenkinson MD, Widhalm G, Neidert M, Picart T, Quoilin
C, Gorlia T, Le Rhun E, Minniti G, Preusser M, Weller M. Addressing the role of
surgery in brain tumour trials: A report from the neurosurgery committee of the
EORTC brain tumour group. Eur J Cancer. 2025 Feb 5;216:115198. doi:
10.1016/j.ejca.2024.115198. Epub 2024 Dec 20. PMID: 39729678.

23: de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ,
Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-
Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi
WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. The role of
vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro
Oncol. 2025 Jun 21;27(5):1135-1148. doi: 10.1093/neuonc/noae259. Erratum in:
Neuro Oncol. 2025 Feb 19:noaf032. doi: 10.1093/neuonc/noaf032. PMID: 39723472;
PMCID: PMC12187374.

24: Tini P, Cinelli E, Yavorska M, Donnini F, Marampon F, Pastina P, Rubino G,
Chibbaro S, Cerase A, Mazzei MA, Di Giacomo AM, Minniti G. Serum lactate
dehydrogenase as a prognostic marker for treatment response in IDH wild-type
glioblastoma patients undergoing stupp protocol. J Neurooncol. 2025
Jan;171(2):413-421. doi: 10.1007/s11060-024-04862-5. Epub 2024 Nov 14. PMID:
39540980.

25: Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, Maccari M,
Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller M, Preusser M, Simonelli
M, Lombardi G. PARP inhibitors in gliomas: Mechanisms of action, current trends
and future perspectives. Cancer Treat Rev. 2024 Dec;131:102850. doi:
10.1016/j.ctrv.2024.102850. Epub 2024 Nov 5. Erratum in: Cancer Treat Rev. 2025
Jan;132:102866. doi: 10.1016/j.ctrv.2024.102866. PMID: 39531943.

26: Rahman R, Preusser M, Tsien C, Le Rhun E, Sulman EP, Wen PY, Minniti G,
Weller M. Point/Counterpoint: The role of reirradiation in recurrent
glioblastoma. Neuro Oncol. 2025 Jan 12;27(1):7-12. doi: 10.1093/neuonc/noae209.
PMID: 39527460; PMCID: PMC11726241.

27: Kotecha R, La Rosa A, Brown PD, Vogelbaum MA, Navarria P, Bodensohn R,
Niyazi M, Karschnia P, Minniti G. Multidisciplinary management strategies for
recurrent brain metastasis after prior radiotherapy: An overview. Neuro Oncol.
2025 Mar 7;27(3):597-615. doi: 10.1093/neuonc/noae220. PMID: 39495010; PMCID:
PMC11889725.

28: Ehret F, El Baya L, Erridge SC, Bussière M, Verhoeff JJC, Niyazi M, Preusser
M, Minniti G, Shih HA. Radiation Therapy for Meningiomas - Where Do We Stand and
What's on the Horizon? Int J Radiat Oncol Biol Phys. 2025 Mar 1;121(3):599-612.
doi: 10.1016/j.ijrobp.2024.10.034. Epub 2024 Oct 28. PMID: 39476990.

29: Baumert BG, P M Jaspers J, Keil VC, Galldiks N, Izycka-Swieszewska E,
Timmermann B, Grosu AL, Minniti G, Ricardi U, Dhermain F, Weber DC, van den Bent
M, Rudà R, Niyazi M, Erridge S. ESTRO-EANO guideline on target delineation and
radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma. Radiother
Oncol. 2025 Jan;202:110594. doi: 10.1016/j.radonc.2024.110594. Epub 2024 Oct 24.
PMID: 39454886.

30: Cicone F, Gnesin S, Santo G, Stokke C, Bartolomei M, Cascini GL, Minniti G,
Paganelli G, Verger A, Cremonesi M. Do we need dosimetry for the optimization of
theranostics in CNS tumors? Neuro Oncol. 2024 Dec 9;26(Supplement_9):S242-S258.
doi: 10.1093/neuonc/noae200. PMID: 39351795; PMCID: PMC11631076.

31: Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P,
Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M. Targeted radionuclide
therapy for patients with central nervous system metastasis: Overlooked
potential? Neuro Oncol. 2024 Dec 9;26(Supplement_9):S229-S241. doi:
10.1093/neuonc/noae192. PMID: 39351771; PMCID: PMC11631097.

32: Yavorska M, Tomaciello M, Sciurti A, Cinelli E, Rubino G, Perrella A, Cerase
A, Pastina P, Gravina GL, Arcieri S, Mazzei MA, Migliara G, Baccolini V,
Marampon F, Minniti G, Di Giacomo AM, Tini P. Predictive value of perilesional
edema volume in melanoma brain metastasis response to stereotactic radiosurgery.
J Neurooncol. 2024 Dec;170(3):611-618. doi: 10.1007/s11060-024-04818-9. Epub
2024 Sep 11. Erratum in: J Neurooncol. 2024 Dec;170(3):619. doi:
10.1007/s11060-024-04832-x. PMID: 39259411; PMCID: PMC11615094.

33: Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N, Jakola AS,
Niyazi M, Smits M, Verger A, Cicone F, Weller M, Preusser M; European
Organisation for Research and Treatment of Cancer Brain Tumor Group. Translating
the theranostic concept to neuro-oncology: disrupting barriers. Lancet Oncol.
2024 Sep;25(9):e441-e451. doi: 10.1016/S1470-2045(24)00145-1. PMID: 39214115.

34: Tini P, Rubino G, Pastina P, Chibbaro S, Cerase A, Marampon F, Paolini S,
Esposito V, Minniti G. Challenges and Opportunities in Accessing Surgery for
Glioblastoma in Low-Middle Income Countries: A Narrative Review. Cancers
(Basel). 2024 Aug 17;16(16):2870. doi: 10.3390/cancers16162870. PMID: 39199641;
PMCID: PMC11352297.

35: Weller M, Remon J, Rieken S, Vollmuth P, Ahn MJ, Minniti G, Le Rhun E,
Westphal M, Brastianos PK, Soo RA, Kirkpatrick JP, Goldberg SB, Öhrling K, Hegi-
Johnson F, Hendriks LEL. Central nervous system metastases in advanced non-small
cell lung cancer: A review of the therapeutic landscape. Cancer Treat Rev. 2024
Nov;130:102807. doi: 10.1016/j.ctrv.2024.102807. Epub 2024 Aug 2. PMID:
39151281.

36: Moltoni G, Romano A, Capriotti G, Campagna G, Ascolese AM, Romano A,
Dellepiane F, Minniti G, Signore A, Bozzao A. ASL, DSC, DCE perfusion MRI and
18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment
changes. Radiol Med. 2024 Sep;129(9):1382-1393. doi: 10.1007/s11547-024-01862-3.
Epub 2024 Aug 8. PMID: 39117936; PMCID: PMC11379733.

37: Nicosia L, Allegra AG, Giaj-Levra N, Bayani R, Darzikolaee NM, Mazzola R,
Pastorello E, Ravelli P, Ricchetti F, Rigo M, Ruggieri R, Gurrera D, Borgese RF,
Gaito S, Minniti G, Navarria P, Scorsetti M, Alongi F. Repeated HyperArc
radiosurgery for recurrent intracranial metastases and dosimetric analysis of
recurrence pattern to account for diffuse dose effect on microscopical disease.
Clin Transl Radiat Oncol. 2024 Jun 24;48:100811. doi:
10.1016/j.ctro.2024.100811. PMID: 39036468; PMCID: PMC11260387.

38: Boele F, Rosenlund L, Nordentoft S, Melhuish S, Nicklin E, Rydén I,
Williamson A, Donders-Kamphuis M, Preusser M, Le Rhun E, Kiesel B, Minniti G,
Furtner J, Dirven L, Taphoorn M, Galldiks N, Rudà R, Chalmers A, Short SC, Piil
K. Inequalities in access to neuro-oncology supportive care and rehabilitation:
A survey of healthcare professionals' perspectives. Neurooncol Pract. 2024 Mar
15;11(4):484-493. doi: 10.1093/nop/npae023. PMID: 39006521; PMCID: PMC11241368.

39: Eekers DBP, Zegers CML, Ahmed KA, Amelio D, Gupta T, Harrabi SB, Kazda T,
Scartoni D, Seidel C, Shih HA, Minniti G. Controversies in neuro-oncology: Focal
proton versus photon radiation therapy for adult brain tumors. Neurooncol Pract.
2024 Apr 29;11(4):369-382. doi: 10.1093/nop/npae040. PMID: 39006517; PMCID:
PMC11241386.

40: Preusser M, Kazda T, Le Rhun E, Sahm F, Smits M, Gempt J, Koekkoek JA, Monti
AF, Csanadi M, Pitter JG, Bulbek H, Fournier B, Quoilin C, Gorlia T, Weller M,
Minniti G; European Organisation for Research, Treatment of Cancer (EORTC) Brain
Tumor Group. Lomustine with or without reirradiation for first progression of
glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III
study. Trials. 2024 Jun 7;25(1):366. doi: 10.1186/s13063-024-08213-7. PMID:
38849943; PMCID: PMC11157762.

41: Wang JZ, Landry AP, Raleigh DR, Sahm F, Walsh KM, Goldbrunner R, Yefet LS,
Tonn JC, Gui C, Ostrom QT, Barnholtz-Sloan J, Perry A, Ellenbogen Y, Hanemann
CO, Jungwirth G, Jenkinson MD, Tabatabai G, Mathiesen TI, McDermott MW, Tatagiba
M, la Fougère C, Maas SLN, Galldiks N, Albert NL, Brastianos PK, Ehret F,
Minniti G, Lamszus K, Ricklefs FL, Schittenhelm J, Drummond KJ, Dunn IF,
Pathmanaban ON, Cohen-Gadol AA, Sulman EP, Tabouret E, Le Rhun E, Mawrin C,
Moliterno J, Weller M, Bi WL, Gao A, Yip S, Niyazi M; International Consortium
on Meningiomas (ICOM); Aldape K, Wen PY, Short S, Preusser M, Nassiri F, Zadeh
G. Meningioma: International Consortium on Meningiomas consensus review on
scientific advances and treatment paradigms for clinicians, researchers, and
patients. Neuro Oncol. 2024 Oct 3;26(10):1742-1780. doi: 10.1093/neuonc/noae082.
PMID: 38695575; PMCID: PMC11449035.

42: Desideri I, Morelli I, Banini M, Greto D, Visani L, Nozzoli F, Caini S,
Della Puppa A, Livi L, Perini Z, Zivelonghi E, Bulgarelli G, Pinzi V, Navarria
P, Clerici E, Scorsetti M, Ascolese AM, Osti MF, Anselmo P, Amelio D, Minniti G,
Scartoni D. Re-irradiation for recurrent intracranial meningiomas: Analysis of
clinical outcomes and prognostic factors. Radiother Oncol. 2024 Jun;195:110271.
doi: 10.1016/j.radonc.2024.110271. Epub 2024 Apr 7. PMID: 38588920.

43: Gaito S, Goyal L, Rieu R, France A, Burnet NG, Barker C, Pan S, Colaco RJ,
Minniti G, Roncaroli F, Smith E, Aznar M, Whitfield G. Radiotherapy
intensification for atypical and malignant meningiomas: A systematic review.
Neurooncol Pract. 2023 Dec 18;11(2):115-124. doi: 10.1093/nop/npad077. PMID:
38496911; PMCID: PMC10940825.

44: Di Nunno V, Lombardi G, Simonelli M, Minniti G, Mastronuzzi A, Di Ruscio V,
Corrà M, Padovan M, Maccari M, Caccese M, Simonetti G, Berlendis A, Farinotti M,
Pollo B, Antonelli M, Di Muzio A, Dipasquale A, Asioli S, De Biase D, Tosoni A,
Silvani A, Franceschi E. The role of adjuvant chemotherapy in patients with
H3K27 altered diffuse midline gliomas: a multicentric retrospective study. J
Neurooncol. 2024 Mar;167(1):145-154. doi: 10.1007/s11060-024-04589-3. Epub 2024
Mar 8. PMID: 38457090.

45: Basile M, Valentini I, Attanasio R, Cozzi R, Persichetti A, Samperi I,
Scoppola A, Auriemma RS, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta
D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S,
Cappabianca P, Paoletta A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG,
Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni
F, Silvani A, Veronese N, Grimaldi F, Papini E, Cicchetti A. A pharmacoeconomic
analysis from Italian guidelines for the management of prolactinomas. Glob Reg
Health Technol Assess. 2024 Jan 9;11:1-16. doi: 10.33393/grhta.2024.2601. PMID:
38230389; PMCID: PMC10788683.

46: Le Rhun E, Boele F, Minniti G, Galldiks N, Taphoorn M, Piil K, Rudà R,
Niclou SP, Geurts M, Preusser M, Weller M, Short SC, Dirven L. Gender balance
and suitable positive actions to promote gender equality among healthcare
professionals in neuro-oncology: The EANO positive action initiative. Neurooncol
Pract. 2023 Oct 3;11(1):46-55. doi: 10.1093/nop/npad064. PMID: 38222048; PMCID:
PMC10785600.

47: Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de
Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short
SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A,
Weller M, Wen PY, Preusser M. PET-based response assessment criteria for diffuse
gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024
Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. PMID: 38181810; PMCID:
PMC11787868.

48: Cerretti G, Pessina F, Franceschi E, Barresi V, Salvalaggio A, Padovan M,
Manara R, Di Nunno V, Bono BC, Librizzi G, Caccese M, Scorsetti M, Maccari M,
Minniti G, Navarria P, Lombardi G. Spinal ependymoma in adults: from molecular
advances to new treatment perspectives. Front Oncol. 2023 Nov 24;13:1301179.
doi: 10.3389/fonc.2023.1301179. PMID: 38074692; PMCID: PMC10704349.

49: Bodensohn R, Maier SH, Belka C, Minniti G, Niyazi M. Stereotactic
Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques.
Cancers (Basel). 2023 Nov 14;15(22):5404. doi: 10.3390/cancers15225404. PMID:
38001664; PMCID: PMC10670108.

50: Guninski RS, Cuccia F, Alongi F, Andratschke N, Belka C, Bellut D, Dahele M,
Josipovic M, Kroese TE, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af
Rosenschold P, Sahgal A, Tsang Y, Verbakel WFAR, Guckenberger M. Efficacy and
safety of SBRT for spine metastases: A systematic review and meta-analysis for
preparation of an ESTRO practice guideline. Radiother Oncol. 2024
Jan;190:109969. doi: 10.1016/j.radonc.2023.109969. Epub 2023 Nov 2. PMID:
37922993.

51: Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N,
Kim MM, Huse JT, Schnell O, Harter PN, Mohme M; Expert Rater Panel; von
Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum
MA, Chang SM, Berger MS, Tonn JC. A framework for standardised tissue sampling
and processing during resection of diffuse intracranial glioma: joint
recommendations from four RANO groups. Lancet Oncol. 2023 Nov;24(11):e438-e450.
doi: 10.1016/S1470-2045(23)00453-9. PMID: 37922934; PMCID: PMC10849105.

52: Guckenberger M, Andratschke N, Belka C, Bellut D, Cuccia F, Dahele M,
Guninski RS, Josipovic M, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af
Rosenschold P, Sahgal A, Tsang Y, Verbakel W, Alongi F. ESTRO clinical practice
guideline: Stereotactic body radiotherapy for spine metastases. Radiother Oncol.
2024 Jan;190:109966. doi: 10.1016/j.radonc.2023.109966. Epub 2023 Nov 2. PMID:
37925107.

53: Romano A, Moltoni G, Blandino A, Palizzi S, Romano A, de Rosa G, De Blasi
Palma L, Monopoli C, Guarnera A, Minniti G, Bozzao A. Radiosurgery for Brain
Metastases: Challenges in Imaging Interpretation after Treatment. Cancers
(Basel). 2023 Oct 21;15(20):5092. doi: 10.3390/cancers15205092. PMID: 37894459;
PMCID: PMC10605307.

54: Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rudà R,
Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S,
Curigliano G, Preusser M; EANO Guidelines Committee and ESMO Guidelines
Committee. Electronic address: clinicalguidelines@esmo.org. Leptomeningeal
metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for
diagnosis, treatment and follow-up. ESMO Open. 2023 Oct;8(5):101624. doi:
10.1016/j.esmoop.2023.101624. Epub 2023 Sep 19. PMID: 37863528; PMCID:
PMC10619142.

55: Minniti G, Paolini S, Antonelli M, Gianno F, Tini P, Lanzetta G, Arcella A,
De Pietro R, Giraffa M, Capone L, Romano A, Bozzao A, Esposito V. Long-term
treatment outcomes of temozolomide-based chemoradiation in patients with adult-
type diffuse IDH-mutant grade 2 astrocytoma. J Neurooncol. 2023
Sep;164(2):331-339. doi: 10.1007/s11060-023-04418-z. Epub 2023 Sep 4. PMID:
37665475; PMCID: PMC10522719.

56: De Pietro R, Zaccaro L, Marampon F, Tini P, De Felice F, Minniti G. The
evolving role of reirradiation in the management of recurrent brain tumors. J
Neurooncol. 2023 Sep;164(2):271-286. doi: 10.1007/s11060-023-04407-2. Epub 2023
Aug 25. PMID: 37624529; PMCID: PMC10522742.

57: Guarnera A, Romano A, Moltoni G, Ius T, Palizzi S, Romano A, Bagatto D,
Minniti G, Bozzao A. The Role of Advanced MRI Sequences in the Diagnosis and
Follow-Up of Adult Brainstem Gliomas: A Neuroradiological Review. Tomography.
2023 Aug 18;9(4):1526-1537. doi: 10.3390/tomography9040122. PMID: 37624115;
PMCID: PMC10457939.

58: De Felice F, Serpone M, Cattaneo CG, Di Giammarco F, Fallico A, Delle Donne
A, Lanzilao M, Vitti E, Marampon F, Musio D, Tombolini V, Minniti G. Definitive
weekly hypofractionated radiotherapy in surgery-ineligible older adults with
cutaneous squamous cell carcinoma of the head and neck region. J Geriatr Oncol.
2024 Jan;15(1):101596. doi: 10.1016/j.jgo.2023.101596. Epub 2023 Jul 28. PMID:
37517887.

59: Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten
M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts
M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W,
Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C,
Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw
M. Correcting the drug development paradigm for glioblastoma requires serial
tissue sampling. Nat Med. 2023 Oct;29(10):2402-2405. doi:
10.1038/s41591-023-02464-8. PMID: 37488293; PMCID: PMC11983287.

60: De Felice F, Serpone M, Cattaneo CG, Di Giammarco F, Fallico A, Delle Donne
A, Lanzilao M, Vitti E, Marampon F, Musio D, Tombolini V, Minniti G. Surgery-
ineligible elderly patients with cutaneous squamous cell carcinoma of the head
and neck region gain clinical benefit from definitive weekly hypofractionated
radiotherapy. Head Neck. 2023 Sep;45(9):2363-2368. doi: 10.1002/hed.27454. Epub
2023 Jul 13. PMID: 37439379.

61: Bodensohn R, Kaempfel AL, Boulesteix AL, Orzelek AM, Corradini S,
Fleischmann DF, Forbrig R, Garny S, Hadi I, Hofmaier J, Minniti G, Mansmann U,
Pazos Escudero M, Thon N, Belka C, Niyazi M. Stereotactic radiosurgery versus
whole-brain radiotherapy in patients with 4-10 brain metastases: A nonrandomized
controlled trial. Radiother Oncol. 2023 Sep;186:109744. doi:
10.1016/j.radonc.2023.109744. Epub 2023 Jun 15. PMID: 37330054.

62: Tini P, Yavoroska M, Mazzei MA, Miracco C, Pirtoli L, Tomaciello M, Marampon
F, Minniti G. Low expression of Ki-67/MIB-1 labeling index in IDH wild type
glioblastoma predicts prolonged survival independently by MGMT methylation
status. J Neurooncol. 2023 Jun;163(2):339-344. doi: 10.1007/s11060-023-04342-2.
Epub 2023 May 25. PMID: 37227648; PMCID: PMC10322955.

63: Tomaciello M, Conte M, Montinaro FR, Sabatini A, Cunicella G, Di Giammarco
F, Tini P, Gravina GL, Cortesi E, Minniti G, De Vincentis G, Frantellizzi V,
Marampon F. Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic
Review and Retrospective Analysis of Challenge within a Challenge. Biomedicines.
2023 Apr 12;11(4):1157. doi: 10.3390/biomedicines11041157. PMID: 37189775;
PMCID: PMC10135682.

64: Cozzi R, Simona Auriemma R, De Menis E, Esposito F, Ferrante E, Iatì G,
Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R,
Vecchi S, Basile M, Cappabianca P, Paoletta A, Papini E, Persichetti A, Samperi
I, Scoppola A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S,
Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani
A, Veronese N, Grimaldi F, Attanasio R. Italian Guidelines for the Management of
Prolactinomas. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1459-1479.
doi: 10.2174/1871530323666230511104045. PMID: 37171003; PMCID: PMC10556400.

65: Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC, Galldiks N,
Lagerwaard FJ, Navarria P, Munck Af Rosenschöld P, Ricardi U, van den Bent MJ,
Weller M, Belka C, Minniti G. ESTRO-EANO guideline on target delineation and
radiotherapy details for glioblastoma. Radiother Oncol. 2023 Jul;184:109663.
doi: 10.1016/j.radonc.2023.109663. Epub 2023 Apr 13. PMID: 37059335.

66: Tini P, Marampon F, Giraffa M, Bucelli S, Niyazi M, Belka C, Minniti G.
Current status and perspectives of interventional clinical trials for brain
metastases: analysis of ClinicalTrials.gov. Radiat Oncol. 2023 Apr 4;18(1):62.
doi: 10.1186/s13014-023-02243-2. PMID: 37016421; PMCID: PMC10074717.

67: Navarria P, Pessina F, Minniti G, Franzese C, Marini B, D'agostino G,
Badalamenti M, Raspagliesi L, Reggiori G, Lobefalo F, Fariselli L, Franceschini
D, Bellu L, Clerici E, Pinzi V, Scorsetti M. Multimodal Treatments for Brain
Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective
Study. Cancers (Basel). 2023 Feb 22;15(5):1393. doi: 10.3390/cancers15051393.
PMID: 36900186; PMCID: PMC10000216.

68: Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R,
Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rudà R,
Tabatabai G, Wen PY, Short SC, Preusser M. Diagnosis and management of
complications from the treatment of primary central nervous system tumors in
adults. Neuro Oncol. 2023 Jul 6;25(7):1200-1224. doi: 10.1093/neuonc/noad038.
PMID: 36843451; PMCID: PMC10326495.

69: Minniti G, Tini P, Giraffa M, Capone L, Raza G, Russo I, Cinelli E, Gentile
P, Bozzao A, Paolini S, Esposito V. Feasibility of clinical target volume
reduction for glioblastoma treated with standard chemoradiation based on
patterns of failure analysis. Radiother Oncol. 2023 Apr;181:109435. doi:
10.1016/j.radonc.2022.11.024. Epub 2022 Dec 16. PMID: 36529439.

70: Feola T, Carbonara F, Verrico M, Di Crescenzo RM, Gianno F, Colonnese C,
Arcella A, de Alcubierre D, Tomao S, Esposito V, Giangaspero F, Minniti G,
Jaffrain-Rea ML. Immunotherapy for Aggressive and Metastatic Pituitary
Neuroendocrine Tumors (PitNETs): State-of-the Art. Cancers (Basel). 2022 Aug
24;14(17):4093. doi: 10.3390/cancers14174093. PMID: 36077631; PMCID: PMC9454884.

71: Nicosia L, Navarria P, Pinzi V, Giraffa M, Russo I, Tini P, Giaj-Levra N,
Alongi F, Minniti G. Stereotactic radiosurgery for the treatment of brainstem
metastases: a multicenter retrospective study. Radiat Oncol. 2022 Aug
9;17(1):140. doi: 10.1186/s13014-022-02111-5. PMID: 35945597; PMCID: PMC9364508.

72: Lombardi G, Poliani PL, Manara R, Berhouma M, Minniti G, Tabouret E, Razis
E, Cerretti G, Zagonel V, Weller M, Idbaih A. Diagnosis and Treatment of Pineal
Region Tumors in Adults: A EURACAN Overview. Cancers (Basel). 2022 Jul
27;14(15):3646. doi: 10.3390/cancers14153646. PMID: 35954310; PMCID: PMC9367474.

73: Rudà R, Capper D, Waldman AD, Pallud J, Minniti G, Kaley TJ, Bouffet E,
Tabatabai G, Aronica E, Jakola AS, Pfister SM, Schiff D, Lassman AB, Solomon DA,
Soffietti R, Weller M, Preusser M, Idbaih A, Wen PY, van den Bent MJ. EANO -
EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and
neuronal tumors. Neuro Oncol. 2022 Dec 1;24(12):2015-2034. doi:
10.1093/neuonc/noac188. PMID: 35908833; PMCID: PMC9713532.

74: Di Nunno V, Fordellone M, Minniti G, Asioli S, Conti A, Mazzatenta D,
Balestrini D, Chiodini P, Agati R, Tonon C, Tosoni A, Gatto L, Bartolini S, Lodi
R, Franceschi E. Machine learning in neuro-oncology: toward novel development
fields. J Neurooncol. 2022 Sep;159(2):333-346. doi: 10.1007/s11060-022-04068-7.
Epub 2022 Jun 28. PMID: 35761160.

75: Raza GH, Capone L, Tini P, Giraffa M, Gentile P, Minniti G. Single-isocenter
multiple-target stereotactic radiosurgery for multiple brain metastases:
dosimetric evaluation of two automated treatment planning systems. Radiat Oncol.
2022 Jul 1;17(1):116. doi: 10.1186/s13014-022-02086-3. PMID: 35778741; PMCID:
PMC9250172.

76: Vagnoni L, Aburas S, Giraffa M, Russo I, Chiarella V, Paolini S, Tini P,
Minniti G. Radiation therapy for atypical and anaplastic meningiomas: an
overview of current results and controversial issues. Neurosurg Rev. 2022
Oct;45(5):3019-3033. doi: 10.1007/s10143-022-01806-3. Epub 2022 Jun 4. PMID:
35665867; PMCID: PMC9492595.

77: Paolini S, Severino R, Mancarella C, Cardarelli G, Ciavarro M, Di
Castelnuovo A, Iacoviello L, Minniti G. Mini-craniotomy for intra-axial brain
tumors: a comparison with conventional craniotomy in 306 patients harboring non-
dural based lesions. Neurosurg Rev. 2022 Aug;45(4):2983-2991. doi:
10.1007/s10143-022-01811-6. Epub 2022 May 18. PMID: 35585468.

78: Le Rhun E, Devos P, Winklhofer S, Lmalem H, Brandsma D, Kumthekar P,
Castellano A, Compter A, Dhermain F, Franceschi E, Forsyth P, Furtner J,
Galldiks N, Gállego Pérez-Larraya J, Gempt J, Hattingen E, Hempel JM, Lukacova
S, Minniti G, O'Brien B, Postma TJ, Roth P, Rudà R, Schaefer N, Schmidt NO,
Snijders TJ, Thust S, van den Bent M, van der Hoorn A, Vogin G, Smits M, Tonn
JC, Jaeckle KA, Preusser M, Glantz M, Wen PY, Bendszus M, Weller M. Prospective
validation of a new imaging scorecard to assess leptomeningeal metastasis: A
joint EORTC BTG and RANO effort. Neuro Oncol. 2022 Oct 3;24(10):1726-1735. doi:
10.1093/neuonc/noac043. PMID: 35157772; PMCID: PMC9527515.

79: Minniti G, Le Rhun E. Should radiotherapy be considered for the initial
treatment of brain metastases? Lancet Oncol. 2022 Feb;23(2):205-206. doi:
10.1016/S1470-2045(21)00696-3. PMID: 35114118.

80: Minniti G, Lanzetta G, Capone L, Giraffa M, Russo I, Cicone F, Bozzao A,
Alongi F, Nicosia L, Fineschi G, Marchetti L, Tufo T, Bianciardi F, Esposito V,
Gentile P, Paolini S. Leptomeningeal disease and brain control after
postoperative stereotactic radiosurgery with or without immunotherapy for
resected brain metastases. J Immunother Cancer. 2021 Dec;9(12):e003730. doi:
10.1136/jitc-2021-003730. PMID: 34949695; PMCID: PMC8705219.

81: Rudà R, Bruno F, Ius T, Silvani A, Minniti G, Pace A, Lombardi G, Bertero L,
Pizzolitto S, Pollo B, Conti Nibali M, Pellerino A, Migliore E, Skrap M, Bello
L, Soffietti R. IDH wild-type grade 2 diffuse astrocytomas: prognostic factors
and impact of treatments within molecular subgroups. Neuro Oncol. 2022 May
4;24(5):809-820. doi: 10.1093/neuonc/noab239. PMID: 34651653; PMCID: PMC9071340.

82: Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks
N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F,
Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P,
Weller M, Preusser M; EANO Executive Board and ESMO Guidelines Committee.
Electronic address: clinicalguidelines@esmo.org. EANO-ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up of patients with brain
metastasis from solid tumours. Ann Oncol. 2021 Nov;32(11):1332-1347. doi:
10.1016/j.annonc.2021.07.016. Epub 2021 Aug 6. PMID: 34364998.

83: Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC,
Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le
Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M. EANO guideline on
the diagnosis and management of meningiomas. Neuro Oncol. 2021 Nov
2;23(11):1821-1834. doi: 10.1093/neuonc/noab150. PMID: 34181733; PMCID:
PMC8563316.

84: Ius T, Tel A, Minniti G, Somma T, Solari D, Longhi M, De Bonis P, Scerrati
A, Caccese M, Barresi V, Fiorentino A, Gorgoglione L, Lombardi G, Robiony M.
Advances in Multidisciplinary Management of Skull Base Meningiomas. Cancers
(Basel). 2021 May 28;13(11):2664. doi: 10.3390/cancers13112664. PMID: 34071391;
PMCID: PMC8198762.

85: Trungu S, Ricciardi L, Forcato S, Scollato A, Minniti G, Miscusi M, Raco A.
Percutaneous carbon-PEEK instrumentation for spine tumors: a prospective
observational study. J Neurosurg Sci. 2023 Jun;67(3):303-310. doi:
10.23736/S0390-5616.21.05153-5. Epub 2021 Apr 16. PMID: 33870663.

86: Minniti G, Niyazi M, Andratschke N, Guckenberger M, Palmer JD, Shih HA, Lo
SS, Soltys S, Russo I, Brown PD, Belka C. Current status and recent advances in
resection cavity irradiation of brain metastases. Radiat Oncol. 2021 Apr
15;16(1):73. doi: 10.1186/s13014-021-01802-9. PMID: 33858474; PMCID: PMC8051036.

87: Castellano A, Bailo M, Cicone F, Carideo L, Quartuccio N, Mortini P, Falini
A, Cascini GL, Minniti G. Advanced Imaging Techniques for Radiotherapy Planning
of Gliomas. Cancers (Basel). 2021 Mar 3;13(5):1063. doi:
10.3390/cancers13051063. PMID: 33802292; PMCID: PMC7959155.

88: Minniti G, Niyazi M, Alongi F, Navarria P, Belka C. Current status and
recent advances in reirradiation of glioblastoma. Radiat Oncol. 2021 Feb
18;16(1):36. doi: 10.1186/s13014-021-01767-9. PMID: 33602305; PMCID: PMC7890828.

89: Galldiks N, Niyazi M, Grosu AL, Kocher M, Langen KJ, Law I, Minniti G, Kim
MM, Tsien C, Dhermain F, Soffietti R, Mehta MP, Weller M, Tonn JC. Contribution
of PET imaging to radiotherapy planning and monitoring in glioma patients - a
report of the PET/RANO group. Neuro Oncol. 2021 Jun 1;23(6):881-893. doi:
10.1093/neuonc/noab013. PMID: 33538838; PMCID: PMC8168815.

90: Combs SE, Baumert BG, Bendszus M, Bozzao A, Brada M, Fariselli L, Fiorentino
A, Ganswindt U, Grosu AL, Lagerwaard FL, Niyazi M, Nyholm T, Paddick I, Weber
DC, Belka C, Minniti G. ESTRO ACROP guideline for target volume delineation of
skull base tumors. Radiother Oncol. 2021 Mar;156:80-94. doi:
10.1016/j.radonc.2020.11.014. Epub 2020 Dec 10. PMID: 33309848.

91: Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G,
Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten
M, Roth P, Rudà R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M,
Soffietti R, Reifenberger G, Wick W. EANO guidelines on the diagnosis and
treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021
Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8. Erratum in:
Nat Rev Clin Oncol. 2022 May;19(5):357-358. doi: 10.1038/s41571-022-00623-3.
PMID: 33293629; PMCID: PMC7904519.

92: Cicone F, Carideo L, Scaringi C, Romano A, Mamede M, Papa A, Tofani A,
Cascini GL, Bozzao A, Scopinaro F, Minniti G. Long-term metabolic evolution of
brain metastases with suspected radiation necrosis following stereotactic
radiosurgery: longitudinal assessment by F-DOPA PET. Neuro Oncol. 2021 Jun
1;23(6):1024-1034. doi: 10.1093/neuonc/noaa239. PMID: 33095884; PMCID:
PMC8168819.